From With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test:

Don Nicholson
Don Nicholson

Don Nicholson is the CEO of Nimbus Therapeutics. Photo courtesy of Jon Chomitz Photography: http://www.chomitz.com/.